slide-ok.png
Winner of

Computerworld Honors 2009 

A European multidisciplinary network for the fight against HIV drug resistance

provetta.jpg

EuResist Network is an international non-profit partnership devoted to understanding and fighting the resistance to anti-HIV drugs.

Its approach is eminentely multidisciplinary and focused on exploiting the power of real world data at the benefit of the individual patient...

The EuResist Integrated Database
with data of more than 105.000 HIV patients is open for research studies.

They talk about us

An algorithm for Africa
Parte a Roma il progetto europeo EUcare
tg.png

TG3 Lazio Region

Local/national TV news 

Forbes_edited.png

"L’Ue investe altri 120 milioni di euro in 11 progetti per contrastare le varianti Covid: ci sono anche due realtà italiane"

Audible by Rai GR Parlamento:

L'Italia che va_F.Incardona_InterviewRai GR Parlamento
00:00 / 06:25
DEF_NUOVO-LOGO-TESTATA_2021_366x100.webp

"La società è stata colpita dal COVID-19 sotto diversi aspetti: uno di questi, in gran parte sottovalutato, è la scuola. Per studiarla abbiamo coinvolto nel progetto anche gli studenti".

"Arruoleremo scuole in contesti socioeconomici diversi e valuteremo con un trial prospettico una metodologia di test salivare di gruppo, rapida ed economica"

Audible by Radio Radicale:

Derrick_blog_RadioRadicale-mp1132380Derrick Blog
00:00 / 02:33

The workshop on COVID-19 organised within the 22nd Arevir-EuResist Meeting  will be focused on EUCARE as a European-project for the investigation of SARS-CoV-2 and epidemics.

Chaired by Francesca Incardona (EuResist) who coordinates the project, Maurizio Zazzi (Università di Siena) and Anders Sönnerborg (Karolinska Institutet), this session will see the participation of Mr. Jan Paehler, EC RTD, Policy Officer. The EuCARE Management Board Members will present the results already achieved in the first six months of the project and the next steps.

The 22nd Arevir- EuResist Meeting (Cologne, 06-07 May 2022) will also cover a broad range of current topics on viral resistance research pertaining to multiple pathogens such as HIV, HCV, HBV and M. Tuberculi.

duomo-di-colonia (1).jpg

The Poster "Declining incidence of HIV multidrug resistance in Europe" has won the Best Poster Award at the 18th European AIDS Conference held Online & London, United Kingdom on October 27–30, 2021.

MDRaward.jpg

The article "Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe" is now published online. Results from a  cohort of over 13.000 INSTI experienced individuals in Europe.


Thanks to all the INTEGRATE working group!

We have been pleased to host in Rome the kick-off meeting of the project EuCARE European Cohorts of Patients and Schools to Advance Response to Epidemics funded by the EC under HORIZON-HLTH-2021-CORONA-01

 

Coordinated by Euresist Network, 22 primary universities, hospitals and ICT research centres are already working to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics. With the support of strong immuno-virological and artificial intelligence components, the study will take advantage of large hospital patients, vaccinated healthcare workers and schools’ cohorts in Europe, Kenya, Mexico, Russia and Vietnam to find an answer to urgent issues related to science and society. 

ALL.JPG

CARE HIV-TB-HCV: EU-Russia cooperation results

Online conference - June 15 2021, 9:00 – 16:00 CEST

The online meeting organised by the CARE Consortium had the objective to present and discuss outcomes and findings from CARE Common Action and other projects and initiatives in the frame of recent collaborative research in the WHO European Region.

 

It has seen the participation of CARE, ARREST-TB, CARE External Scientific Advisory Board, CARE External Ethics Review Board, Russian experts, NDPHS, Russian Ministry of Health, Russian Ministry of Science and Higher Education, EC, EU Delegation to the Russian Federation.

CARE-logo-ok.png

1st April 2021 https://vimeo.com/event/832587

 

The marginal role of schools as a center for spreading the infection, when the necessary containment measures are adopted, is now demonstrated by most of the scientific literature. However, doubts remain in society and in the political world, especially as regards high schools and relatively to the spread of viral variants.
On the contrary, the costs of closure are not yet fully known and are still likely to be underestimated.

The webinar sponsored by EuResist Network will support the scientific discussion on these themes while involving both the civil society and the political institutions.

With the participation of scientists as Antonella D'arminio Monforte, Sara Gandini, Daniele Novara, of associations as Save the Children, AcrionAid, ForumDD, of members of the Italian Parliament and of the Minister for Equal Opportunities and the Family Elena Bonetti.

Seminario-1°-aprile--(7b).png
CAREnewsletterWP2_edited.jpg
CAREnewsletterWP3.png
CAREnewsletterWP4.png
CAREnewsletterWP5-6.png

EuCARE: European Cohorts of Patients and Schools to Advance Response to Epidemics

WorldMap_edited.png

Coordinated by Euresist Network, 22 primary universities, hospitals and ICT research centres are collaborating to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics. 

How do SARS-COV-2 variants, coupled with other factors, influence the clinical course of COVID-19? Is there any vaccine or test escape related to variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy  in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?

With the support of strong immuno-virological and artificial intelligence components, the study will take advantage of large hospital patients, vaccinated healthcare workers and schools’ cohorts in Europe, Kenya, Mexico, Russia and Vietnam to find an answer to urgent issues related to science and society....

CARE

IMG_2297.JPG

​CARE (Common Action against HIV/TB/HCV across the Regions of Europe) aims at analysing and addressing the human immunodeficiency virus (HIV), tuberculosis (TB) and hepatitis C (HCV) epidemics across Europe and Russia, by establishing new networks and consolidating previous cooperative actions between the European Union and the Russian Federation. 

MDR

Logo_JPG-1 copia.jpg

The MDR project (HIV multidrug resistance pathways in the EuResist Integrated DataBase) aims at estimating the prevalence and trend over time of MDR (multidrug resistance) in HIV patients, using descriptive statistics, retaining high value because of the large sample size and wide representativeness of the EIDB.

​​​The INTEGRATE project aims at building and maintaining a large, curated collection of virological and clinical data to increase scientific knowledge on resistance to integrase strand transfer inhibitors (InSTI) and on the most appropriate use of this class of antiretroviral agents.

EuResist Mentor School

EuResist Network organises the EuResist Mentor School (EMS) an innovative educational project finalised to train young physicians and biologists in dealing with structured data (databases). The EMS 2018 has been successfully held in Cologne 

EuResist in Africa

EuResist has been supporting partner of the EDCTP networking action: "Integrated training activities and IT infrastructures to improve capacities in eastern African area"...

EucoHIV

EucoHIV is an independent self-constituted study group aiming at increasing scientific knowledge on HIV coreceptor usage and its clinical significance, including...

fotoandreamau.png

Ciao Andrea.

 

On Feb 4th 2019, our great friend and EuResister Andrea De Luca lost his life in a horrible car accident, at the age of 55.

One year has passed and still we miss him with incredulity and sorrow. 
Among many other projects,  Andrea joined EuResist as a key leader soon after its launch, devoting his energy, commitment and capability to the success of the Network. He was an extra lively, smart, passionate, and positive person, always ready to help and take new tasks.
His loss is a huge loss for us, for his patients, for his beloved ones, for the international research community.

Ciao Andrea, we'll always miss you.